Diana N. Ionescu

600 W 10th Ave, V5Z 4E6
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies.

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026

MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.

MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026

Targeting common EGFR mutations in non-small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors.

Targeting common EGFR mutations in non-small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors.

Journal: Journal of the National Cancer Institute
Published: October 24, 2025

Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing Workflow.

Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing Workflow.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 24, 2025

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma.

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma.

Journal: Current oncology (Toronto, Ont.)
Published: October 23, 2024

Lung Cancer in Romania.

Lung Cancer in Romania.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 02, 2024

Reduced wait times for molecular-biomarker testing among patients with advanced lung cancer using parallel sample processing and closed-loop communication: the Continuous Oncopanel and ALK Status Tracking (COAST) Project.

Reduced wait times for molecular-biomarker testing among patients with advanced lung cancer using parallel sample processing and closed-loop communication: the Continuous Oncopanel and ALK Status Tracking (COAST) Project.

Journal: BMJ open quality
Published: July 10, 2024

Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.

Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: March 13, 2024

Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.

Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.

Journal: Human pathology
Published: August 10, 2023

The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung.

The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung.

Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2023

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: June 09, 2023

Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.

Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 16, 2023
Showing 1-12 of 68

Last Updated: 09/26/2026